Edasalonexent is under investigation in clinical trial NCT01511900 (A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.